Title : Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis.

Pub. Date : 2011 Nov

PMID : 21471566






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To assess the safety and efficacy of the B lymphocyte (anti-CD20) antibody, rituximab, in the treatment of steroid-resistant moderately active ulcerative colitis (UC). Steroids keratin 20 Homo sapiens